← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksJNJEarnings History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargetsShould I Buy?

JNJ logoJohnson & Johnson (JNJ) Earnings History

Annual and quarterly earnings data from 1989 to 2024

TTM Net Income
$25.12B
Profitable
TTM EPS
$10.34
Diluted
YoY EPS Growth
-57.8%
Declining
Net Margin
15.8%
Profitability
Operating Margin24.9%
Gross Margin69.1%
ROE20.1%
ROA8.1%
Highest Annual Net Income$35.15B (2023)
Highest Quarterly EPS$10.21 (Q3 2023)
Consecutive Profitable Years36 years
Q3 2025
Net Income$5.15B
EPS$2.12
QoQ Growth-7.0%Slow

Loading earnings history...

JNJ EPS Growth (CAGR)

Compound annual growth rate of diluted earnings per share

1-Year
-57.8%
Declining
3-Year
-9.5%
Slow
5-Year
+0.6%
Solid
10-Year
+0.2%
Solid

CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.

JNJ Profitability Analysis

Margin trends over time

View revenue breakdown →
YearGross MarginOperating MarginNet Margin
202469.1%24.9%15.8%
202368.8%27.5%41.3%
202269.3%26.3%22.4%
202170.3%26.6%26.5%
202065.6%23.9%17.8%
Gross Margin = Gross Profit ÷ Revenue
Operating Margin = Operating Income ÷ Revenue
Net Margin = Net Income ÷ Revenue

Download Data

Export JNJ earnings history in CSV or JSON format

Free sign-in required to download data

Johnson & Johnson (JNJ) Earnings Overview

As of May 6, 2026, Johnson & Johnson (JNJ) reported trailing twelve-month net income of $25.12B, reflecting -57.8% year-over-year growth. The company earned $10.34 per diluted share over the past four quarters, with a net profit margin of 15.8%.

Looking at the long-term picture, JNJ's 5-year EPS compound annual growth rate (CAGR) stands at +0.6%, reflecting modest earnings expansion. The company achieved its highest annual net income of $35.15B in fiscal 2023.

Johnson & Johnson maintains industry-leading profitability with a gross margin of 69.1%, operating margin of 24.9%, and net margin of 15.8%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →

Compared to peers including ABT ($13.98B net income, 31.9% margin), PFE ($7.49B net income, 12.4% margin), MRK ($18.25B net income, 28.1% margin), JNJ has room to improve margins relative to the peer group. Compare JNJ vs ABT →

JNJ Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
JNJ logoJNJCurrent
$25.1B$10.3415.8%20.1%-57.8%—
ABT logoABT
$14.0B$7.9931.9%30.9%+133.6%
PFE logoPFE
$7.5B$1.3112.4%8.9%-3.5%
MRK logoMRK
$18.3B$7.3428.1%36.9%+8.0%
LLY logoLLY
$25.3B$28.2131.7%101.2%+96.0%
BMY logoBMY
$7.3B$3.5614.6%40.4%+178.2%
Best in group
Lowest in group

JNJ Historical Earnings Data (1989–2024)

36 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2024$14.07B-60.0%$22.15B$5.7915.8%24.9%
2023$35.15B+95.9%$23.41B$13.7241.3%27.5%
2022$17.94B-14.1%$21.01B$6.7322.4%26.3%
2021$20.88B+41.9%$20.94B$7.8126.5%26.6%
2020$14.71B-2.7%$19.73B$5.5117.8%23.9%
2019$15.12B-1.2%$20.97B$5.6318.4%25.6%
2018$15.30B+1076.7%$21.18B$5.6118.8%26.0%
2017$1.30B-92.1%$18.90B$0.471.7%24.7%
2016$16.54B+7.3%$20.89B$5.9323.0%29.1%
2015$15.41B-5.6%$18.29B$5.4822.0%26.1%

Full JNJ Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

Should I Buy JNJ Right Now?

Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.

See Verdict

See JNJ's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is JNJ Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare JNJ vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

JNJ — Frequently Asked Questions

Quick answers to the most common questions about buying JNJ stock.

Is JNJ growing earnings?

JNJ EPS fell to $10.34, with earnings declining -57.8%. This contrasts with the 5-year CAGR of +0.6%. TTM net income dropped to $25.1B.

What are JNJ's profit margins?

Johnson & Johnson net margin is +15.8%, with operating margin at +24.9%. Above-average margins indicate pricing power.

How consistent are JNJ's earnings?

JNJ earnings data spans 1989-2024. The declining earnings trend is -57.8% YoY. Historical data enables comparison across business cycles.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

JNJ Earnings Over Time (2013–2024)

Net income and EPS trends